Results

Bayer Corporation

09/14/2021 | Press release | Distributed by Public on 09/14/2021 13:40

NUBEQA® (darolutamide) Impact on Local Symptoms Evaluated in Men with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)